URSO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 318
EU - Europa 157
AS - Asia 143
OC - Oceania 4
SA - Sud America 4
Totale 626
Nazione #
US - Stati Uniti d'America 318
IT - Italia 99
SG - Singapore 53
CN - Cina 35
FI - Finlandia 18
ID - Indonesia 18
IN - India 14
DE - Germania 13
VN - Vietnam 12
GB - Regno Unito 10
SE - Svezia 7
HK - Hong Kong 6
CZ - Repubblica Ceca 5
AU - Australia 4
KR - Corea 3
AR - Argentina 2
BR - Brasile 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
NL - Olanda 1
PT - Portogallo 1
Totale 626
Città #
Chandler 60
Shanghai 35
New York 30
Singapore 26
Ashburn 25
Ferrara 20
Milan 19
Fairfield 18
Jakarta 18
Dong Ket 12
Helsinki 11
Bologna 10
Houston 10
Boardman 8
Lappeenranta 7
Wilmington 7
Cambridge 6
Ferrara di Monte Baldo 6
Hong Kong 6
Princeton 6
Bremen 5
Brno 5
Parma 5
Poggio Renatico 5
San Diego 5
Woodbridge 5
Seattle 4
Sydney 4
Addison 3
Ann Arbor 3
Chicago 3
Copparo 3
Florence 3
Frankfurt am Main 3
Hounslow 3
Kochi 3
London 3
Alpharetta 2
Chandigarh 2
Cipolletti 2
Dej 2
Forlì 2
Incheon 2
Istanbul 2
Los Angeles 2
Maglie 2
Occhiobello 2
Padova 2
Pelotas 2
Reggio Emilia 2
Sandston 2
Alzano Lombardo 1
Amsterdam 1
Atlanta 1
Bhubaneswar 1
Cheongju-si 1
Delhi 1
Falls Church 1
Indore 1
Kilburn 1
Leawood 1
Lisbon 1
New Bedfont 1
Pavia 1
Portomaggiore 1
Southwark 1
Stienta 1
Vienna 1
Washington 1
Totale 451
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 89
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 55
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 47
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 42
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 31
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 30
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 29
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 28
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 26
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 23
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 22
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 18
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 18
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 15
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 14
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 14
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 14
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 13
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 13
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 13
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 12
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 10
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 9
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 8
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 8
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 7
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 7
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 7
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 7
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 7
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 7
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 7
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 7
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 6
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 6
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 6
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 6
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 6
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 6
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 6
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 5
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 5
Clinical applications of long axial field-of-view PET/CT scanners in oncology 4
Molecular imaging of PARP in cancer: state-of-the-art 4
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 3
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 3
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 3
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 3
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 2
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 2
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 1
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 1
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 1
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 1
Totale 737
Categoria #
all - tutte 7.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 1 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/202556 56 0 0 0 0 0 0 0 0 0 0 0
Totale 737